Canopy Growth Launches Spectrum Cannabis Softgels

The Simplicity of the SpectrumTM Meets the Sophistication of Softgels

SMITHS FALLS, ON, June 18, 2018 /CNW/ – Spectrum Cannabis (“Spectrum Cannabis”), the global medical subsidiary of Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (NYSE: CGC) is proud to announce the introduction of convenient, colour-coded Softgels to its product line in Canada. These innovative new products, available today, provide patients and healthcare professionals with a consistent dosing format for ingestible medical cannabis, supporting simplified dosing and a simplified conversation between patients and their healthcare practitioners.

It is Medical Cannabis. Simplified.TM

Launching Spectrum Cannabis Softgels embodies our ongoing commitment to medical customers. Spectrum Cannabis will continue to offer the best products available with a focus on innovative, easy-to-dose and understand options. Delivering these new, extract based Softgels is another success as we focus on providing solutions for the patients who depend on medical cannabis and the healthcare professionals who prescribe it.

Mark Zekulin, President, Canopy Growth

Each coloured Softgel aligns to the broader Spectrum Cannabis offering and contains a different ratio of THC and CBD to give patients clear options while also supporting healthcare professionals’ ability to make consistent treatment recommendations.

The newly introduced Spectrum Softgels are the latest cannabis extract product introduced by the Company and reflect the growing desire for easy to use, medical cannabis products that go beyond whole-flower. As the clinical work of Canopy Health Innovations accelerates, value-add Spectrum Cannabis products will form the backbone of the Company’s ambitious global clinical research framework.

Spectrum Softgels are produced to exacting standards in the Smiths Falls GMP-1 certified production campus. Thanks to investments in industrial-scale facilities, customers and healthcare professionals can choose Spectrum Cannabis with the confidence that access won’t be restrained by inadequate supply.

Knowing that product availability continues to be a challenge in the cannabis industry in Canada, and to back up its commitment to medical patients in the lead-up to recreational legalization, the Company is committing to its customers that Spectrum Cannabis Softgels and oils will always be in stock moving forward.

Launching Spectrum Cannabis Softgels builds on recent announcements that upon the passing of the Cannabis Act, the Company will absorb the proposed excise tax on all Spectrum Cannabis products sold in Canada, including our new Softgels offering. On top of this, all Spectrum Cannabis dried flower products will be priced at $8.50 per gram or less and, as always, Spectrum Cannabis products in Canada are eligible for our industry-first Compassionate Pricing Program that helps those on limited incomes afford their medicine.

Spectrum Cannabis: Medical Cannabis. Simplified.TM

About Spectrum Cannabis

Spectrum Cannabis, a wholly-owned subsidiary of Canopy Growth, is dedicated to simplifying medical cannabis for patients and healthcare practitioners. Spectrum Cannabis is an international medical business which interfaces with healthcare professionals and patients around the world. Founded in Canada, Spectrum Cannabis operates in Australia, South America, Africa and across Europe. Spectrum Cannabis products are available in a wide range of potencies and formats designed to simplify the dialogue around strength and dosage by applying a colour-coded Spectrum to categorize medical cannabis according to THC and CBD levels. Its product lineup includes whole flower cannabis, oils and new innovations such as Softgels. Through product simplification, easy dosing formats, its Compassionate Pricing Program, in addition to ongoing education of healthcare professionals, Spectrum is committed to improving the lives of medical cannabis patients around the globe.

About Canopy Growth Corporation

Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates ten licensed cannabis production sites with over 2.4 million square feet of production capacity, including over 500,000 square feet of GMP-certified production space. The Company has operations in nine countries across five continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis. Through its partly owned subsidiary, Canopy Health Innovations, Canopy Growth has invested millions of dollars toward cutting edge, commercializable research and IP development. Through its partly owned subsidiary Canopy Rivers Corporation, the Company provides resources and investment to new market entrants in order to build a portfolio of stable investments in the sector. From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. For more information visit

Original press release

Get ahead of the crowd by signing up for 420 Investor when it becomes available again. It’s the largest & most comprehensive premium service for cannabis investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter